Adaptimmune Therapeutics PLC
SEC CIK 1621227 · ADAP] · last insider filing 2025-10-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Behbahani Ali | Director | filed 2016 - 2025 |
| Rawcliffe Adrian | Director · Chief Financial Officer | filed 2016 - 2025 |
| Mott David M | Director | filed 2016 - 2024 |
| Hege Kristen | Director | filed 2023 - 2024 |
| Allen Andrew R | Director | filed 2023 - 2024 |
| Alleva Lawrence M | Director | filed 2016 - 2024 |
| Menzel Garry E | Director | filed 2023 - 2024 |
| Furey John | Director | filed 2018 - 2024 |
| Hegde Priti | Director | filed 2023 - 2024 |
| Sigal Charles Elliott | Director | filed 2016 - 2023 |
| Duncan Barbara Gayle | Director | filed 2016 - 2022 |
| Noble James | Director · Chief Executive Officer | filed 2016 - 2022 |
| Zaks Tal Zvi | Director | filed 2016 - 2022 |
| Kerr Giles Francis Bertram | Director | filed 2016 - 2019 |
| Orbimed Advisors LLC | Director | filed 2016 - 2018 |
| Thompson Peter A. | Director | filed 2016 - 2018 |
| Orbimed Capital GP V LLC | Director | filed 2016 - 2018 |
| Isaly Samuel D | Director | filed 2016 - 2017 |
| Laing Ian Michael | Director | filed 2016 - 2016 |
| Knowles Jonathan Kenneth Charles | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hill Christopher James | Chief Financial Officer | filed 2025 - 2025 |
| Wood Gavin | Chief Financial Officer | filed 2020 - 2025 |
| Bertrand William C JR | Chief Operating Officer | filed 2017 - 2025 |
| Lunger John | Chief Patient Supply Officer | filed 2019 - 2025 |
| Norry Elliot | Chief Medical Officer | filed 2020 - 2025 |
| Piccina Cintia | Chief Commercial Officer | filed 2022 - 2025 |
| Brewer Joanna Elizabeth | Chief Scientific Officer | filed 2022 - 2025 |
| Tayton-Martin Helena Katrina | Chief Operating Officer | filed 2016 - 2024 |
| Garone Michael | Interim CFO | filed 2019 - 2019 |
| Amado Rafael | President, R&D | filed 2016 - 2019 |
| Binder-Scholl Gwendolyn Knowlton | EVP, Adaptimmune LLC | filed 2016 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.